Eisai Financial Statements From 2010 to 2024
| EII Stock | EUR 26.12 0.20 0.76% |
Check Eisai financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eisai's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eisai financial statements analysis is a perfect complement when working with Eisai Valuation or Volatility modules.
Eisai |
Eisai Co Company Operating Margin Analysis
Eisai's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Eisai Operating Margin | (0.02) % |
Most of Eisai's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eisai Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Eisai Co has an Operating Margin of -0.0248%. This is 99.93% lower than that of the Healthcare sector and 99.93% lower than that of the Drug Manufacturers - Specialty & Generic industry. The operating margin for all Germany stocks is 99.55% lower than that of the firm.
Eisai Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eisai's current stock value. Our valuation model uses many indicators to compare Eisai value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eisai competition to find correlations between indicators driving Eisai's intrinsic value. More Info.Eisai Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eisai's earnings, one of the primary drivers of an investment's value.About Eisai Financial Statements
Eisai stakeholders use historical fundamental indicators, such as Eisai's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eisai investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eisai's assets and liabilities are reflected in the revenues and expenses on Eisai's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eisai Co. Please read more on our technical analysis and fundamental analysis pages.
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan. EISAI LTD operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10683 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Eisai Stock
Eisai financial ratios help investors to determine whether Eisai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai security.